Market Access Enablement Strategies, Part 2: Navigating Policy and Marketplace Developments

Summary

Join Avalere experts for Part 2 of our Market Access Enablement Strategies webinar series to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans, and pharmacy benefit managers.

Access Recording

Recent pricing and policy developments may create major shifts in plan design and preparation. Join our policy and market access experts to evaluate forward-leaning considerations and perspectives for how to best prepare for these developments and adapt your business strategies.

Key Topics

Executive orders related to drug pricing (e.g., rebate rule, importation, international pricing index, 340B)
State-level regulation and legislation
CMS’s proposed value-based purchasing rule: possible impact on manufacturers, healthcare plans, and PBMs
COVID-19 impacts and coverage shifts

Panelists

Moderator

Sarah Butler , Head, Client Solutions, Marketing & Operations

Sarah Butler specializes in evidence-based medicine, value-based contracting, and strategy development.

Speaker

Lance Grady , Executive Vice President, Life Sciences Strategy & Growth

Lance Grady is the head of Avalere’s Life Sciences Strategy & Growth.

Speaker

John C. Neal , Managing Director, Commercialization & Regulatory Strategy

John Neal partners with pharmaceutical and biotechnology clients to develop market access assessments and launch strategies to ensure successful asset commercialization.

Speaker

Megan West (Olsen) , Managing Director, Policy

Megan West advises clients on policy and market-based strategies related to drug pricing, cell and gene therapy (CGT) development, value-based contracting, and innovative approaches to patient access.